Natera

Billing Strategy Lead, Denials and Appeals

United States

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
HealthcareIndustries

Position Overview

  • Location Type: [Not Specified]
  • Employment Type: [Not Specified]
  • Salary: [Not Specified]

This role seeks a Billing Strategy Lead, Denials & Appeals to manage strategic programs focused on revenue cycle operations, particularly denials and appeals management. The ideal candidate will be data-savvy, experienced in healthcare revenue cycle processes, and skilled at managing stakeholders and timelines.

Responsibilities

  • Lead strategic initiatives related to denials and appeals, including transitioning offshore billing operations in-house and establishing new billing workflows or teams.
  • Act as a subject matter expert in revenue cycle and healthcare reimbursement, especially in backend functions such as appeals, denials, and claims workflows.
  • Drive collaboration across Billing Strategy, Operations, Data Analytics, and Engineering teams to ensure deliverables are met, timelines are tracked, and blockers are addressed.
  • Manage and audit vendors; support vendor transition planning, oversight, and implementation of new billing technologies or processes.
  • Translate data into operational insights through the use of dashboards, reporting, and Business Intelligence tools (Excel, PowerBI, or Tableau); provide data-driven insights to aid in operational strategy.
  • Utilize project planning and tracking using tools such as Drawio, Smartsheet, or other project trackers to ensure accountability across teams and deliver clear, concise status updates to leadership.
  • Organize and lead recurring cross-functional meetings to review project progress, manage risks, and ensure alignment on priorities and timelines.
  • Provide high-quality documentation and communications including project plans, audit summaries, transition roadmaps, and status updates.
  • Balance hands-on management of projects with strategic planning—pivoting and adapting as needed to meet evolving business demands.

Qualifications

  • Bachelor’s degree in a relevant field (e.g., Biology, Health Administration, Business) or equivalent years of professional experience.
  • 2–4 years of project or program management experience in healthcare or biotech.
  • At least 5 years of direct experience in revenue cycle operations and denials management.
  • Proven experience with denials and appeals management and implementing process improvements in a healthcare reimbursement setting.
  • Experience leading large initiatives involving vendor transitions, standing up new internal teams, or shifting billing operations in-house.
  • Strong experience working with data and KPIs; proficiency with Excel is required, and familiarity with SQL, PowerBI or Tableau is strongly preferred.
  • Certification or formal training in Program or Project Management (PMP, Agile, etc.) is a plus.
  • Experience with [Not Specified]

Skills

Revenue Cycle Management
Denials and Appeals
Healthcare Reimbursement
Data Analytics
Dashboard Reporting
PowerBI
Tableau
Project Planning
Stakeholder Management
Vendor Management
Process Improvement

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI